https://www.clinicaltrials.gov/ct2/show/NCT04035668
A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren’s Syndrome (LOUiSSe)
LOU064
Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers
Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers
Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers
